» Articles » PMID: 10311399

The Economic Costs of Illness: a Replication and Update

Overview
Specialty Health Services
Date 1986 Mar 6
PMID 10311399
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

The economic burden resulting from illness, disability, and premature death is of major importance in the allocation of health care resources and in the evaluation of health research and programs. This article updates the 1963 and 1972 studies of the costs of illness. In 1980, the estimated total economic costs of illness were $455 billion: $211 billion for direct costs, $68 billion for morbidity, and $176 billion for mortality. Diseases of the circulatory system and injuries and poisonings were the most costly, with variations in the diagnostic distributions among the three types of costs and by age and sex.

Citing Articles

Rationale and design of Dapagliflozin vErsus SacubiTrIl-valsartaN therapY in Heart Failure with reduced ejection fraction (DESTINY-HF): a pragmatic randomised controlled trial protocol.

Tiwari K, Deora S, Choudhary R, Kaushik A, Dwivedi P, Singh S BMJ Open. 2024; 14(10):e089562.

PMID: 39424390 PMC: 11492940. DOI: 10.1136/bmjopen-2024-089562.


Costs of medical evacuation and transportation of First Nations Peoples and Inuit who travel for medical care in Canada: A systematic review.

Radhaa M, Leason J, Twalibu A, Davis E, Fletcher C, Lawford K Can J Public Health. 2024; 116(1):5-25.

PMID: 39394337 PMC: 11867983. DOI: 10.17269/s41997-024-00945-y.


Lifetime costs of alcohol consumption in Thailand: protocol for an incidence-based cost-of-illness study using Markov model.

Luangsinsiri C, Thavorncharoensap M, Chaikledkaew U, Pattanaprateep O, Sornpaisarn B, Rehm J BMJ Open. 2024; 14(4):e079829.

PMID: 38684264 PMC: 11086458. DOI: 10.1136/bmjopen-2023-079829.


The Economic Burden of the COVID-19 Pandemic in State of Kuwait.

Nur A, Aljunid S, Almari M Clinicoecon Outcomes Res. 2024; 16:111-122.

PMID: 38463550 PMC: 10921943. DOI: 10.2147/CEOR.S442913.


The 30 Years of Shifting in The Indonesian Cardiovascular Burden-Analysis of The Global Burden of Disease Study.

Muharram F, Multazam C, Mustofa A, Socha W, Andrianto , Martini S J Epidemiol Glob Health. 2024; 14(1):193-212.

PMID: 38324147 PMC: 11043320. DOI: 10.1007/s44197-024-00187-8.


References
1.
Oster G, Colditz G, Kelly N . The economic costs of smoking and benefits of quitting for individual smokers. Prev Med. 1984; 13(4):377-89. DOI: 10.1016/0091-7435(84)90029-x. View

2.
Hodgson T, Kopstein A . Health care expenditures for major diseases in 1980. Health Care Financ Rev. 1985; 5(4):1-12. PMC: 4191353. View

3.
Linnerooth J . The value of human life: a review of the models. Econ Inq. 1978; 17(1):52-74. DOI: 10.1111/j.1465-7295.1979.tb00295.x. View

4.
Hodgson T, Meiners M . Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc. 1982; 60(3):429-62. View

5.
. Cost of disease and illness in the United States in the year 2000. Public Health Rep. 1978; 93(5):493-588. PMC: 1431938. View